Skip to main content
. 2017 Dec 21;57(7):1027–1031. doi: 10.2169/internalmedicine.9586-17

Table 2.

The Changes in the UPDRS Part III Score and Levodopa Dose.

Baseline After 4 weeks After 9 weeks
MDS-UPDRS part III
Total score 39 19 20
1 Speech 2 1 1
2 Facial expression 2 2 3
3 Rigidity - neck 1 0 0
- RUE 2 0 0
- RLE 0 0 0
- LUE 1 0 0
- LLE 0 0 0
4 Finger tapping - Right 1 0 1
- Left 1 1 0
5 Hand movements - Right 1 1 1
- Left 1 2 2
6 Pronation-Supination movements of hands - Right 1 1 1
- Left 2 2 1
7 Toe tapping - Right 1 0 0
- Left 1 0 0
8 Leg agility - Right 0 0 0
- Left 0 0 0
9 Arising from chair 0 3 1
10 Gait 1 0 1
11 Freezing of gait 0 0 0
12 Postural stability 0 0 1
13 Posture 1 1 1
14 Global spontaneity of movement 1 1 2
15 Posturaltremor of the hands - Right 1 0 0
- Left 1 1 1
16 Kinetic tremor of the hands - Right 2 0 0
- Left 2 1 1
17 Rest tremor amplitude - RUE 3 0 0
- RLE 2 0 0
- LUE 3 1 1
- LLE 2 0 0
- Lip/Jaw 0 0 0
18 Constancy of rest tremor 3 1 1
L-dopa 300mg 300mg 250mg

RUE: right upper extremity, RLE: right lower extremity, LUE: left upper extremity, LLE: left lower extremity